Journal article
Reevaluation of RINT1 as a breast cancer predisposition gene
N Li, ER Thompson, SM Rowley, S McInerny, L Devereux, D Goode, LP Investigators, MW Wong-Brown, RJ Scott, AH Trainer, KL Gorringe, PA James, IG Campbell
Breast Cancer Research and Treatment | SPRINGER | Published : 2016
Abstract
Rad50 interactor 1 (RINT1) has recently been reported as an intermediate-penetrance (odds ratio 3.24) breast cancer susceptibility gene, as well as a risk factor for Lynch syndrome. The coding regions and exon–intron boundaries of RINT1 were sequenced in 2024 familial breast cancer cases previously tested negative for BRCA1, BRCA2, and PALB2 mutations and 1886 population-matched cancer-free controls using HaloPlex Targeted Enrichment Assays. Only one RINT1 protein-truncating variant was detected in a control. No excess was observed in the total number of rare variants (truncating and missense) (28, 1.38 %, vs. 27, 1.43 %. P > 0.999) or in the number of variants predicted to be pathogenic by ..
View full abstractRelated Projects (1)
Grants
Funding Acknowledgements
This work was supported by the National Breast Cancer Foundation, Cancer Australia, the Victorian Cancer Agency, and the National Health and Medical Research Council of Australia.